Back

Lipoprotein (a) and new-onset type-2 diabetes in patients with familial combined hyperlipidemia: a 9 years follow-up study

28 August 2022 (11:15 - 12:00)
Organised by:
Congress Presentation Part of: Lipids 3 Lipids ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Ioannis Andrikou

Hippokration General Hospital, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
Awareness of lipid guideline recommendations for high-risk patients amongst primary care physicians in Canada
Doctor M. Gupta (Toronto, CA)
Abstract Slides
Presentation thumbnail
Comparison over 25 years of the burden of familial hypercholesterolemia on hospitalizations for coronary heart disease in a french-canadian founder population
Doctor D. Brisson (Chicoutimi, CA)
Abstract Slides
Presentation thumbnail
Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition
Professor J. Kastelein (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Comparison of severe hypercholesterolemia patients with and without pathogenic variants
Doctor D. Nanchen (Lausanne, CH)
Abstract Slides
Presentation thumbnail
The association between cholesterol remnants and cardiac structure and function
Miss E. Galatius (Gentofte, DK)
Abstract Slides

Access the full session

Session thumbnail
Lipids 3

The Event

Event poster

ESC Congress 2022

28 August 2022 11:15 CET
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Congress Presentation
State-of-the-art lecture on how to keep your arteries young by tackling dyslipidaemia

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources